$2.49T
Total marketcap
$67.4B
Total volume
BTC 50.20%     ETH 16.09%
Dominance

Anteris AMEUF Stock

15.53 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
282.57M USD
LOW - HIGH [24H]
15.53 - 15.53 USD
VOLUME [24H]
68 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.8 USD

Anteris Price Chart

Anteris AMEUF Financial and Trading Overview

Anteris stock price 15.53 USD
Previous Close 14.6 USD
Open 14.85 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 14.85 - 15.14 USD
52 Week Range 11.82 - 20.5 USD
Volume 1.02K USD
Avg. Volume 417 USD
Market Cap 234.41M USD
Beta (5Y Monthly) 0.590038
PE Ratio (TTM) N/A
EPS (TTM) -2.8 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

AMEUF Valuation Measures

Enterprise Value 198.01M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 51.068394
Price/Book (mrq) 15.914827
Enterprise Value/Revenue 43.138
Enterprise Value/EBITDA -4.272

Trading Information

Anteris Stock Price History

Beta (5Y Monthly) 0.590038
52-Week Change 0.43%
S&P500 52-Week Change 20.43%
52 Week High 20.5 USD
52 Week Low 11.82 USD
50-Day Moving Average 14.92 USD
200-Day Moving Average 15.24 USD

AMEUF Share Statistics

Avg. Volume (3 month) 417 USD
Avg. Daily Volume (10-Days) 210 USD
Shares Outstanding 15.49M
Float 10.43M
Short Ratio N/A
% Held by Insiders 17.22%
% Held by Institutions 28.15%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:10

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -1032.35%
Gross Margin 56.83%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -111.84%
Return on Equity (ttm) -321.70%

Income Statement

Revenue (ttm) 4.59M USD
Revenue Per Share (ttm) 0.34 USD
Quarterly Revenue Growth (yoy) -54.40%
Gross Profit (ttm) 2.61M USD
EBITDA -46354168 USD
Net Income Avi to Common (ttm) -44340160 USD
Diluted EPS (ttm) -2.32
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 13.81M USD
Total Cash Per Share (mrq) 0.99 USD
Total Debt (mrq) 1.41M USD
Total Debt/Equity (mrq) 10.64 USD
Current Ratio (mrq) 2.396
Book Value Per Share (mrq) 0.951

Cash Flow Statement

Operating Cash Flow (ttm) -38995192 USD
Levered Free Cash Flow (ttm) -24997556 USD

Profile of Anteris

Country United States
State QLD
City Toowong
Address Toowong Tower
ZIP 4066
Phone 61 13 0055 0310
Website https://www.anteristech.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees N/A

Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.

Q&A For Anteris Stock

What is a current AMEUF stock price?

Anteris AMEUF stock price today per share is 15.53 USD.

How to purchase Anteris stock?

You can buy AMEUF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Anteris?

The stock symbol or ticker of Anteris is AMEUF.

Which industry does the Anteris company belong to?

The Anteris industry is Medical Devices.

How many shares does Anteris have in circulation?

The max supply of Anteris shares is 18.2M.

What is Anteris Price to Earnings Ratio (PE Ratio)?

Anteris PE Ratio is now.

What was Anteris earnings per share over the trailing 12 months (TTM)?

Anteris EPS is -2.8 USD over the trailing 12 months.

Which sector does the Anteris company belong to?

The Anteris sector is Healthcare.